L. J. M. Evers

998 total citations
10 papers, 125 citations indexed

About

L. J. M. Evers is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, L. J. M. Evers has authored 10 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in L. J. M. Evers's work include Congenital heart defects research (7 papers), Congenital Heart Disease Studies (5 papers) and Genetics and Neurodevelopmental Disorders (3 papers). L. J. M. Evers is often cited by papers focused on Congenital heart defects research (7 papers), Congenital Heart Disease Studies (5 papers) and Genetics and Neurodevelopmental Disorders (3 papers). L. J. M. Evers collaborates with scholars based in Netherlands, Canada and United Kingdom. L. J. M. Evers's co-authors include J.J.M. Engelen, L.M.G. Curfs, Thérèse van Amelsvoort, Leopold Curfs, Marjan Drukker, Math J. J. M. Candel, Jaap Bakker, C. T. R. M. Schrander‐Stumpel, Harm Boer and Christine de Die‐Smulders and has published in prestigious journals such as The British Journal of Psychiatry, Psychopharmacology and The International Journal of Neuropsychopharmacology.

In The Last Decade

L. J. M. Evers

10 papers receiving 123 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. J. M. Evers Netherlands 8 96 67 45 37 15 10 125
María Obón Spain 5 58 0.6× 49 0.7× 34 0.8× 11 0.3× 2 0.1× 11 132
Carol Knightly United States 3 62 0.6× 30 0.4× 54 1.2× 56 1.5× 14 0.9× 3 99
Barbara Kellam Canada 7 25 0.3× 33 0.5× 6 0.1× 26 0.7× 7 0.5× 7 114
Dorthe Seitzberg Denmark 7 47 0.5× 26 0.4× 24 0.5× 75 2.0× 3 0.2× 16 379
Stephanie Harris United States 9 45 0.5× 48 0.7× 18 0.4× 11 0.3× 3 0.2× 11 169
Lieve Verstraete France 7 52 0.5× 62 0.9× 4 0.1× 12 0.3× 8 0.5× 7 157
Abigail R. Benkert United States 7 72 0.8× 41 0.6× 14 0.3× 7 0.2× 2 0.1× 17 139
Liliana Fernández United States 6 49 0.5× 87 1.3× 6 0.1× 5 0.1× 10 0.7× 8 151
Yannis Trakadis Canada 8 69 0.7× 101 1.5× 6 0.1× 3 0.1× 16 1.1× 15 157
Laura A. Tseng Netherlands 7 53 0.6× 83 1.2× 25 0.6× 3 0.1× 5 0.3× 10 158

Countries citing papers authored by L. J. M. Evers

Since Specialization
Citations

This map shows the geographic impact of L. J. M. Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. J. M. Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. J. M. Evers more than expected).

Fields of papers citing papers by L. J. M. Evers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. J. M. Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. J. M. Evers. The network helps show where L. J. M. Evers may publish in the future.

Co-authorship network of co-authors of L. J. M. Evers

This figure shows the co-authorship network connecting the top 25 collaborators of L. J. M. Evers. A scholar is included among the top collaborators of L. J. M. Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. J. M. Evers. L. J. M. Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vingerhoets, Claudia, Oswald Bloemen, Erik Boot, et al.. (2019). Low prevalence of substance use in people with 22q11.2 deletion syndrome. The British Journal of Psychiatry. 215(5). 661–667. 12 indexed citations
2.
Evers, L. J. M., et al.. (2016). The use of two different MLPA kits in 22q11.2 deletion syndrome. European Journal of Medical Genetics. 59(4). 183–188. 3 indexed citations
3.
Evers, L. J. M., et al.. (2015). Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome. Psychopharmacology. 232(18). 3319–3325. 14 indexed citations
4.
Bloemen, Oswald, Jan Booij, L. J. M. Evers, et al.. (2015). P.6.f.005 Prevalence of substance use and the relation with psychosis and catechol-O-methyltransferase in patients with chromosome 22q11 deletion syndrome. European Neuropsychopharmacology. 25. S630–S630. 1 indexed citations
5.
Evers, L. J. M., Leopold Curfs, Jaap Bakker, et al.. (2014). Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome. The International Journal of Neuropsychopharmacology. 17(8). 1159–1165. 15 indexed citations
6.
Evers, L. J. M., Thérèse van Amelsvoort, Math J. J. M. Candel, et al.. (2014). Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability. Journal of Intellectual Disability Research. 58(10). 915–925. 24 indexed citations
7.
Evers, L. J. M., et al.. (2009). The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at adult age.. PubMed. 20(4). 307–15. 15 indexed citations
8.
Evers, L. J. M., et al.. (2006). The velocardiofacial syndrome in older age: dementia and autistic features.. PubMed. 17(3). 333–40. 10 indexed citations
9.
Evers, L. J. M., C. T. R. M. Schrander‐Stumpel, J.J.M. Engelen, et al.. (1996). Deletion of the long arm of chromosome 6: two new patients and literature review. Clinical Genetics. 50(3). 138–144. 21 indexed citations
10.
Evers, L. J. M., C. T. R. M. Schrander‐Stumpel, J.J.M. Engelen, et al.. (1993). Terminal deletion of long arm of chromosome 4: patient report and literature review.. PubMed. 4(2). 139–45. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026